Instrumentation Laboratory HemosIL Direct Thrombin Inhibitor - HSA Registration DE0508285
Access comprehensive regulatory information for Instrumentation Laboratory HemosIL Direct Thrombin Inhibitor in the Singapore medical device market through Pure Global AI's free database. This CLASS C IVD medical device is registered under HSA registration number DE0508285 and owned by Instrumentation Laboratory Company. The device was registered on July 12, 2023.
This page provides complete registration details including product owner information, registrant details, importer information, and regulatory compliance data from the official Singapore HSA medical device database. Pure Global AI offers free access to Singapore's complete medical device registry, helping global MedTech companies navigate HSA regulations efficiently.
The HemosIL Direct Thrombin Inhibitor (DTI) Assay is an in vitro diagnostic assay for the quantitative determination of the Direct Thrombin Inhibitor Dabigatran in citrated human plasma on the ACL TOP Family of analyzers. The product is intended to be used for the measurement of active Dabigatran levels in situations where measurement is warranted.